The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
by The Investment U Research Team
One of the best phrases we may have heard all month came this morning from Reuters’ author Nick Carey, “green shoots do not a harvest make.” We couldn’t have summed it better.
Many of the early “green shoots” have since withered and died.
The market surge we saw from March 6 represented an overabundance of enthusiasm that the worst was over and that recovery was now taking place. The facts paint a strikingly different picture of a long, drawn out recovery.
The message that we’re going to have to have a little more patience seems be sinking in, global confidence is down for the first time in four months. Adding to all this “good news,” analyst Jeffrey deGraaf recently suggested that the S&P 500 could stagnate for years.
This is in addition to reports that the United States and Europe are about to see a huge wave of bankruptcies.
So pack it up and go home, right? Wrong.
Even in this market and these challenging economic conditions, there are profits to be made. Louis Basenese told readers to “dump GE,” and many who did saw 30%+ gains.
Last week we told you to look at AIG as a value play, and readers that did are looking at 70%+ in a mere matter of days.
There is money to be made here, you just need to keep you eyes open for the opportunities. Or you could continue to read the web’s trusted source for investment ideas and investment education.
- Ben’s Back, And So is Real Estate
- Housing Numbers: The Truth Behind It All
- The Economic Recovery: Have Stock Values Gone From Green to Yellow to Red?
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed